Evolution and Impact of a Regional Reperfusion System for ST-Elevation Myocardial Infarction

Christopher B Fordyce1, John A Cairns1, Joel Singer2

  • 1Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.

Insights

A regional system improved access to primary percutaneous coronary intervention (pPCI) for ST-elevation myocardial infarction (STEMI) and reduced treatment times. However, overall clinical outcomes did not improve, suggesting pPCI may not benefit all STEMI patients in regional care models.

Area of Science:

  • Cardiology
  • Health Systems Research

Background:

  • ST-elevation myocardial infarction (STEMI) requires timely reperfusion.
  • Primary percutaneous coronary intervention (pPCI) is the preferred reperfusion strategy.
  • Regional systems aim to optimize STEMI care delivery.

Purpose of the Study:

  • To describe the evolution of a regional STEMI system focused on pPCI.
  • To evaluate the impact of this system on reperfusion times and in-hospital outcomes.

Main Methods:

  • Analysis of 2503 STEMI patients from June 2007 to January 2015.
  • Categorization into three phases: reperfusion algorithms, prehospital ECGs, and expedited interfacility transfer.
  • Multivariable logistic regression to analyze outcomes by phase and hospital type.

Main Results:

  • Regional pPCI use increased significantly across phases (55.0% to 86.7%).
  • Median first medical contact (FMC)-to-device times decreased in both PCI-capable and non-PCI-capable hospitals.
  • Overall in-hospital mortality and congestive heart failure (CHF) rates remained unchanged; however, PCI-capable hospitals showed trends toward increased mortality and higher CHF rates.

Conclusions:

  • The regional STEMI model enhanced pPCI access and reduced reperfusion times.
  • Prolonged FMC-to-device times persisted for some patients, and overall clinical outcomes did not improve.
  • A universal pPCI strategy may not be universally beneficial within regional STEMI care models.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
439
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K